Celldex Therapeutics Market Cap

Celldex Therapeutics has a market cap or net worth of $2.27 billion as of October 15, 2026. It is the 6,139th most valuable company in the world and the 1,681st biggest in the United States. Its market cap has increased by 29.24% in one year.

Market Cap

2.27B

Enterprise Value

1.56B

1-Year Change

29.24%

Global Rank

#6,139

Country Rank

#1,681 United States

ChartMarket Cap Chart

Chart

Since March 10, 2008, Celldex Therapeutics's market cap has increased from $47.20M to $2.27B, an increase of 4,713.26%. That is a compound annual growth rate of 23.14%.

Market Cap History

Date	Market Cap	% Change
Oct 15, 2026	2.27B	25.88%
Dec 31, 2025	1.80B	7.65%
Dec 31, 2024	1.68B	-10.56%
Dec 29, 2023	1.87B	-10.70%
Dec 30, 2022	2.10B	16.42%
Dec 31, 2021	1.80B	160.11%
Dec 31, 2020	693.20M	1,825.56%
Dec 31, 2019	36.00M	5.57%
Dec 31, 2018	34.10M	-91.17%
Dec 29, 2017	386.20M	7.76%
Dec 30, 2016	358.40M	-76.83%
Dec 31, 2015	1.55B	-5.39%
Dec 31, 2014	1.64B	-16.73%
Dec 31, 2013	1.96B	372.13%
Dec 31, 2012	415.90M	262.28%
Dec 30, 2011	114.80M	-13.10%
Dec 31, 2010	132.10M	-10.50%
Dec 31, 2009	147.60M	17.99%
Dec 31, 2008	125.10M	165.04%
Mar 10, 2008	47.20M	-

View and export this data all the way back to 2008. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Beam Therapeutics	2.36B
MBX Biosciences	2.35B
ADMA Biologics	2.32B
Aurinia Pharmaceuticals	2.21B
Harmony Biosciences Holdings	2.18B
Disc Medicine	2.14B
Pharvaris	2.11B
Novavax	2.08B

Market Cap Rankings